Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc - Class A

1
NAS:IRWD (USA)   Class A
$ 9.48 -5.64 (-37.3%) 03:39 PM EST
At Loss
Volume:
26.98M
Avg Vol (2M):
3.35M
Also Trade In:
Volume:
26.98M
At Loss
Avg Vol (2M):
3.35M

Business Description

Ironwood Pharmaceuticals Inc logo
Ironwood Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US46333X1081

Share Class Description:

IRWD: Class A
Description
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset -0.74
Debt-to-Equity -2.07
Debt-to-EBITDA -0.77
Interest Coverage 7.82
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -8.97
Distress
Grey
Safe
Beneish M-Score -3.92
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 5.5
3-Year FCF Growth Rate 4.3
Name Current Vs Industry Vs History
5-Day RSI 58.42
9-Day RSI 60.2
14-Day RSI 63.02
6-1 Month Momentum % 46.98
12-1 Month Momentum % 18.81

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.84
Quick Ratio 0.84
Cash Ratio 0.33
Days Sales Outstanding 99.57

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 0.9
Shareholder Yield % -9.53

Financials (Next Earnings Date:2024-05-03 Est.)

IRWD's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IRWD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ironwood Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 442.735
EPS (TTM) ($) -6.51
Beta 0.56
Volatility % 40.65
14-Day RSI 63.02
14-Day ATR ($) 0.428489
20-Day SMA ($) 14.9655
12-1 Month Momentum % 18.81
52-Week Range ($) 8.075 - 15.7
Shares Outstanding (Mil) 156.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ironwood Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Ironwood Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Ironwood Pharmaceuticals Inc Frequently Asked Questions

What is Ironwood Pharmaceuticals Inc(IRWD)'s stock price today?
The current price of IRWD is $9.48. The 52 week high of IRWD is $15.70 and 52 week low is $8.07.
When is next earnings date of Ironwood Pharmaceuticals Inc(IRWD)?
The next earnings date of Ironwood Pharmaceuticals Inc(IRWD) is 2024-05-03 Est..
Does Ironwood Pharmaceuticals Inc(IRWD) pay dividends? If so, how much?
Ironwood Pharmaceuticals Inc(IRWD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1